Whalestream has ceased operations permanently
Healthcare Sector
Market Tracker
15m Chart - Support and Resistance levels are based on the large dark pool & equity prints at the plotted levels. Displays strongest levels above and below the spot price.
Represents the strikes that had the highest premium of whale flow (on the ASK side) over the past 5 trading days.
Represents the strikes that had the highest premium of whale flow (on the BID side) over the past 5 trading days.
Represents the largest cumulative premium levels above and below the current spot price. The price in the pink bubble represents the spot price.
Total Open Interest of Calls & Puts across all strikes and expirations over the past 16 trading days.
| Expires | Type | Strike | OI | Change | Percent |
|---|---|---|---|---|---|
| 07/17/2026 | PUT | $126.00 | 795 | +705 | +783.33% |
| 09/18/2026 | CALL | $150.00 | 1,987 | +612 | +44.51% |
| 09/18/2026 | CALL | $130.00 | 5,723 | +546 | +10.55% |
| 07/10/2026 | CALL | $130.00 | 1,825 | +456 | +33.31% |
| 07/17/2026 | PUT | $123.00 | 347 | +300 | +638.30% |
| 07/10/2026 | PUT | $106.00 | 299 | +272 | +1,007.41% |
| 01/21/2028 | CALL | $80.00 | 120 | -36 | -23.08% |
| 09/18/2026 | PUT | $110.00 | 5,240 | -38 | -0.72% |
| 07/17/2026 | PUT | $110.00 | 2,558 | -46 | -1.77% |
| 09/18/2026 | PUT | $75.00 | 2,145 | -49 | -2.23% |
| 07/17/2026 | CALL | $130.00 | 5,930 | -71 | -1.18% |
| 01/15/2027 | CALL | $120.00 | 5,490 | -208 | -3.65% |
Contracts with largest changes in open interest from the previous trading day to the current/most recent.
| Name | Pct Held | Shares | Total |
|---|---|---|---|
| Vanguard Total Stock Market Index Fund | 3.04% | 77.07M | 8.28B |
| Vanguard 500 Index Fund | 2.31% | 58.61M | 6.3B |
| Fidelity 500 Index Fund | 1.09% | 27.79M | 2.99B |
| SPDR S&P 500 ETF Trust | 1.08% | 27.45M | 2.95B |
| iShares Core S&P 500 ETF | 0.89% | 22.63M | 2.43B |
| Vanguard Index-Value Index Fund | 0.86% | 21.91M | 2.35B |
| Select Sector SPDR Fund-Health Care | 0.81% | 20.59M | 2.21B |
| Vanguard Specialized-Health Care Fund | 0.72% | 18.31M | 1.97B |
| Vanguard Institutional Index Fund-Institutional Index Fund | 0.70% | 17.77M | 1.91B |
| Schwab Strategic Tr-Schwab U.S. Dividend Equity ETF | 0.68% | 17.38M | 1.87B |
Vanguard Health Care vs. VanEck Pharmaceutical: How Do These ETFs Stack Up?
07/09 08:15 am
The Motley Fool
Read moreBBH vs. XPH: Which Healthcare ETF Is Better for Beginners?
07/08 07:28 am
The Motley Fool
Read moreThe Dividend ETF Quietly Outperforming the S&P 500
07/07 05:30 am
The Motley Fool
Read moreModerna Stock Is Soaring. Is It Too Late to Buy?
07/07 05:15 am
The Motley Fool
Read more3 Dividend ETF Picks That Could Build Serious Long-Term Wealth
07/05 05:20 pm
The Motley Fool
Read moreModerna vs. Recursion: Which Cutting-Edge Pharma Stock Is a Better Buy in 2026?
07/03 11:14 am
The Motley Fool
Read moreWant Decades of Passive Income? Buy This ETF and Hold It Forever.
07/03 07:27 am
The Motley Fool
Read moreBig Pharma Has a Case of Merger Mania
06/30 12:26 am
The Motley Fool
Read moreGlobal HPV Vaccines Market to Grow Rapidly at a CAGR of ~8% by 2034 | DelveInsight
06/24 01:00 pm
GlobeNewswire Inc.
Read moreQuestex’s PODD, the Premier Gathering for Drug Delivery Industry Leaders, Announces the 16th Annual Conference Agenda
06/23 08:00 am
GlobeNewswire Inc.
Read moreCutaneous Lupus Erythematosus Market to Expand at a CAGR of 8% During the Forecast Period (2026–2036) Amid Emerging Therapies and Increasing Healthcare Investments | DelveInsight
06/22 01:00 pm
GlobeNewswire Inc.
Read moreModerna Has Some Key Approvals Ahead. Is the Stock a Buy?
06/20 07:30 am
The Motley Fool
Read moreStock Market Today, June 18: Pfizer Falls as CFO Transition Tests Confidence in 2026 Outlook
06/18 07:09 pm
The Motley Fool
Read moreFDA Expands Merck Pneumococcal Shot Label To Include At-Risk Children And Teens
06/18 11:29 am
Benzinga
Read more3 Dividend Stocks to Hold for the Long Haul
06/16 06:15 am
The Motley Fool
Read moreMetastatic Prostate Cancer Market Set for Robust Growth Through 2036, Driven by The Emergence of PARP Inhibitors and PSMA-targeted Radioligand Therapies | DelveInsight
06/10 01:00 pm
GlobeNewswire Inc.
Read moreGilead And Merck End Trodelvy-Keytruda Lung Cancer Trial
06/09 01:44 pm
Benzinga
Read moreLilly Just Announced 3 Infectious Disease Acquisitions in 1 Day. Is This the Beginning of Its Post-Obesity Growth Strategy?
06/08 05:23 pm
The Motley Fool
Read moreGlobal Sustainability Awards 2026 Opens Final Call for Entries as Industry Leaders Prepare to Celebrate Sustainability Excellence
06/02 09:00 am
GlobeNewswire Inc.
Read moreModerna Reports Strong 5-Year Cancer Vaccine Data, Expands CEPI Partnership; Stock Falls
06/01 12:39 pm
Benzinga
Read moreGlioblastoma Multiforme Market Poised for Significant Growth at a CAGR of 13.2% During the Forecast Period (2026–2036), as Next-Generation Therapies Enter Late-Stage Development | DelveInsight
05/27 01:00 pm
GlobeNewswire Inc.
Read moreTherini Bio Doses First Patients in Phase 1b Trial of Novel Anti-Inflammatory Therapy, THN391, for Diabetic Macular Edema
05/27 10:00 am
GlobeNewswire Inc.
Read more3 Dividend Stocks to Hold for the Next 10 Years
05/25 01:23 pm
The Motley Fool
Read moreS&P 500 Rally Defies Weak Sentiment and Hawkish Fed Signals
05/22 12:04 pm
Investing.com
Read moreOorja Bio Launches as a Clinical-Stage Company to Develop Groundbreaking Therapies for Idiopathic Pulmonary Fibrosis (IPF) and Other Fibrotic Diseases
05/19 03:00 pm
GlobeNewswire Inc.
Read moreWhy Is Regeneron Stock Sinking Monday?
05/18 06:28 am
Benzinga
Read moreCancer Centers Race To Access Revolution Medicines' Pancreatic Cancer Treatment: Report
05/15 11:47 am
Benzinga
Read moreGlobal Colorectal Cancer Diagnostics and Therapeutics Market Anticipates Impressive Growth Trajectory at a CAGR of ~9% by 2034 | DelveInsight
05/13 01:00 pm
GlobeNewswire Inc.
Read moreErasca Announces Clinical Trial Collaboration and Supply Agreement with Merck to Evaluate ERAS-0015 in Combination with KEYTRUDA® (Pembrolizumab)
05/11 07:00 am
GlobeNewswire Inc.
Read more2 Dividend Stocks to Double Up On Right Now
05/08 01:30 pm
The Motley Fool
Read moreImmutrin appoints leading cardiovascular drug development expert Dr. Robert Blaustein as Chief Medical Officer and establishes US subsidiary
05/06 07:00 am
GlobeNewswire Inc.
Read moreInVitria Showcases Exbumin® and Optibumin® 25 at IPEC Excipient World: Biologics Summit: Recombinant Human Serum Albumins Already Used in On-Market Approved Biologics
05/01 08:00 am
GlobeNewswire Inc.
Read moreMerck Swings To Quarterly Loss On Cidara Deal
04/30 01:10 pm
Benzinga
Read moreBulk Filtration Market Report 2026, Competitive Analysis of 3M, Eaton, Parker-Hannifin, Pentair, Merck, Danaher, Mann+Hummel - Analyst Recommendations and Global Forecast to 2031
04/28 10:00 am
GlobeNewswire Inc.
Read moreAntibiotic Resistance Market to Grow at 5.4% CAGR Reaching USD 12.72 Billion by 2031, Driven by Rising Drug-Resistant Infections and Antimicrobial Innovation: Mordor Intelligence
04/28 03:52 am
GlobeNewswire Inc.
Read moreAI Disruption in Lung Cancer Therapeutics Set to Transform Treatment Paradigms as Billion-Dollar Investments Drive Innovation
04/27 01:36 pm
GlobeNewswire Inc.
Read morePeripheral T-Cell Lymphoma Market to Witness Significant Expansion at a CAGR of 7% During the Forecast Period (2026–2036) Amid Advancing Treatment Landscape | DelveInsight
04/27 01:00 pm
GlobeNewswire Inc.
Read more3 Biotech Stocks That Could Benefit from the Patent Cliff
04/27 11:29 am
Investing.com
Read moreMental Health Clinical Trials Research Report 2026: $4.89 Bn Market Opportunities, Trends, Competitive Landscape, Strategies, and Forecasts, 2020-2025, 2025-2030F, 2035F
04/24 04:57 am
GlobeNewswire Inc.
Read moreLarge Drugmakers Eye Inhibrx Cancer Drugs Valued Over $8 Billion, Stock Surges
04/22 02:20 pm
Benzinga
Read morePolycythemia Vera Market Set for Transformation: Key 9 Companies Expected to Enter by 2036 | DelveInsight
04/22 01:00 pm
GlobeNewswire Inc.
Read moreVulvar Cancer Market Global and Regional Analysis Report 2025-2035, Profiles of Merck & Co., Bristol Myers Squibb, and AstraZeneca
04/22 05:59 am
GlobeNewswire Inc.
Read moreWhy Is Merck Stock Falling Tuesday?
04/21 01:42 pm
Benzinga
Read moreFollicular Lymphoma Clinical Trial Space Intensifies with 45+ Companies in Active Development | DelveInsight
04/21 01:00 pm
GlobeNewswire Inc.
Read moreOncolytic Virus Immunotherapy Market Landscape Report 2026: A $5 Opportunity by 2031 - Technology Platforms, Approved Therapy Dosage, Price & Clinical Trials Insights
04/21 04:14 am
GlobeNewswire Inc.
Read more